Hoppenot, D. 2018. OMALIZUMAB: SEVERE ALLERGIC ASTHMA TREATMENT OPTION. Pulmonology and allergology. 2, 1 (May 2018), 68-73. DOI:https://doi.org/10.37499/PIA.201.